Cellab CDMO is a dedicated partner for advancing cell therapy solutions within the pharmaceutical industry. As an End-to-End Contract Development and Manufacturing Organization (CDMO), Cellab specializes in supporting therapy developers to progress their Advanced Therapy Medicinal Products from initial concept and early-stage development through to clinical programmes and eventual commercialization. Their mission is to accelerate the development of ATMPs from bench to bedside, with a strong commitment to excellence, rigorous adherence to quality standards, and compliance with regulatory requirements. With an agile approach, the company can swiftly adapt to the evolving needs of products, ensuring timely delivery and success.

Services include:
- Cell and Gene Therapy
- Drug Substance Manufacturing (API)
- Research & Development
- Clinical Trial Materials
- Packaging
- Analytical Methods Development

Cellab is focused on providing comprehensive solutions to meet the demands of the pharmaceutical industry, ensuring that clients' needs are met with precision and efficiency. For more information, please visit cellab.com.